These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32649026)

  • 1. Alzheimer's disease risk modifier genes do not affect tau aggregate uptake, seeding or maintenance in cell models.
    Kolay S; Diamond MI
    FEBS Open Bio; 2020 Sep; 10(9):1912-1920. PubMed ID: 32649026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau
    Stopschinski BE; Holmes BB; Miller GM; Manon VA; Vaquer-Alicea J; Prueitt WL; Hsieh-Wilson LC; Diamond MI
    J Biol Chem; 2018 Jul; 293(27):10826-10840. PubMed ID: 29752409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo.
    Stancu IC; Cremers N; Vanrusselt H; Couturier J; Vanoosthuyse A; Kessels S; Lodder C; Brône B; Huaux F; Octave JN; Terwel D; Dewachter I
    Acta Neuropathol; 2019 Apr; 137(4):599-617. PubMed ID: 30721409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.
    Vasconcelos B; Stancu IC; Buist A; Bird M; Wang P; Vanoosthuyse A; Van Kolen K; Verheyen A; Kienlen-Campard P; Octave JN; Baatsen P; Moechars D; Dewachter I
    Acta Neuropathol; 2016 Apr; 131(4):549-69. PubMed ID: 26739002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease.
    Farmer KM; Ghag G; Puangmalai N; Montalbano M; Bhatt N; Kayed R
    Acta Neuropathol Commun; 2020 Aug; 8(1):132. PubMed ID: 32778161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.
    Marreiro A; Van Kolen K; Sousa C; Temmerman L; Vasconcelos B; Crespo-Rodriguez R; van Weering JRT; Van Dam D; De Deyn PP; Apetri A; Schoofs L; Mercken MH
    BMC Mol Cell Biol; 2020 Nov; 21(1):81. PubMed ID: 33183222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Chemokine-like Receptor 1 Deficiency Improves Cognitive Deficits of AD Mice and Attenuates Tau Hyperphosphorylation via Regulating Tau Seeding.
    Zhang H; Lin A; Gong P; Chen Y; Ye RD; Qian F; Zhang Y; Yu Y
    J Neurosci; 2020 Sep; 40(36):6991-7007. PubMed ID: 32801154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic heparinoid blocks Tau aggregate cell uptake and amplification.
    Stopschinski BE; Thomas TL; Nadji S; Darvish E; Fan L; Holmes BB; Modi AR; Finnell JG; Kashmer OM; Estill-Terpack S; Mirbaha H; Luu HS; Diamond MI
    J Biol Chem; 2020 Mar; 295(10):2974-2983. PubMed ID: 31974166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific detection of tau seeding activity in Alzheimer's disease using rationally designed biosensor cells.
    Lathuiliere A; Jo Y; Perbet R; Donahue C; Commins C; Quittot N; Fan Z; Bennett RE; Hyman BT
    Mol Neurodegener; 2023 Aug; 18(1):53. PubMed ID: 37553663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological Changes of Tau Related to Alzheimer's Disease.
    Chu D; Liu F
    ACS Chem Neurosci; 2019 Feb; 10(2):931-944. PubMed ID: 30346708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
    Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
    Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo.
    Vergara C; Houben S; Suain V; Yilmaz Z; De Decker R; Vanden Dries V; Boom A; Mansour S; Leroy K; Ando K; Brion JP
    Acta Neuropathol; 2019 Mar; 137(3):397-412. PubMed ID: 30599077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.
    Wu R; Gu J; Zhou D; Tung YC; Jin N; Chu D; Hu W; Wegiel J; Gong CX; Iqbal K; Liu F
    J Alzheimers Dis; 2021; 79(4):1647-1659. PubMed ID: 33459649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
    Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
    Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
    Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
    J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteopathic tau seeding predicts tauopathy in vivo.
    Holmes BB; Furman JL; Mahan TE; Yamasaki TR; Mirbaha H; Eades WC; Belaygorod L; Cairns NJ; Holtzman DM; Diamond MI
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):E4376-85. PubMed ID: 25261551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans-cellular propagation of Tau aggregation by fibrillar species.
    Kfoury N; Holmes BB; Jiang H; Holtzman DM; Diamond MI
    J Biol Chem; 2012 Jun; 287(23):19440-51. PubMed ID: 22461630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease.
    Catania M; Di Fede G
    Prog Mol Biol Transl Sci; 2020; 175():213-237. PubMed ID: 32958234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.